178 related articles for article (PubMed ID: 17617119)
1. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
[TBL] [Abstract][Full Text] [Related]
2. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
Weltman MD; Farrell GC; Hall P; Ingelman-Sundberg M; Liddle C
Hepatology; 1998 Jan; 27(1):128-33. PubMed ID: 9425928
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.
Chalasani N; Gorski JC; Asghar MS; Asghar A; Foresman B; Hall SD; Crabb DW
Hepatology; 2003 Mar; 37(3):544-50. PubMed ID: 12601351
[TBL] [Abstract][Full Text] [Related]
4. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
[TBL] [Abstract][Full Text] [Related]
5. Chlorzoxazone 6-hydroxylase and p-nitrophenol hydroxylase as the most suitable activities for assaying cytochrome P450 2E1 in cynomolgus monkey liver.
Amato G; Longo V; Mazzaccaro A; Gervasi PG
Drug Metab Dispos; 1998 May; 26(5):483-9. PubMed ID: 9571230
[TBL] [Abstract][Full Text] [Related]
6. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.
Leclercq IA; Farrell GC; Field J; Bell DR; Gonzalez FJ; Robertson GR
J Clin Invest; 2000 Apr; 105(8):1067-75. PubMed ID: 10772651
[TBL] [Abstract][Full Text] [Related]
7. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC
Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008
[TBL] [Abstract][Full Text] [Related]
8. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.
Washington K; Wright K; Shyr Y; Hunter EB; Olson S; Raiford DS
Hum Pathol; 2000 Jul; 31(7):822-8. PubMed ID: 10923919
[TBL] [Abstract][Full Text] [Related]
9. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
[TBL] [Abstract][Full Text] [Related]
10. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
Gebhardt AC; Lucas D; Ménez JF; Seitz HK
Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319
[TBL] [Abstract][Full Text] [Related]
11. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity.
Raucy JL; Schultz ED; Wester MR; Arora S; Johnston DE; Omdahl JL; Carpenter SP
Drug Metab Dispos; 1997 Dec; 25(12):1429-35. PubMed ID: 9394034
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
Eap CB; Schnyder C; Besson J; Savary L; Buclin T
Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
[TBL] [Abstract][Full Text] [Related]
13. [A clinicopathological study on nonalcoholic steatohepatitis].
Lang ZW; Hu ZJ; Wang SK; Zhang LJ; Meng X; Song CZ
Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):81-3. PubMed ID: 12648399
[TBL] [Abstract][Full Text] [Related]
14. Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics.
Plee-Gautier E; Foresto F; Ferrara R; Bodénez P; Simon B; Manno M; Berthou F; Lucas D
Alcohol Clin Exp Res; 2001 Jun; 25(6):800-4. PubMed ID: 11410713
[TBL] [Abstract][Full Text] [Related]
15. [NASH -- nonalcoholic steatohepatitis].
Blechacz B; Stremmel W
Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
[TBL] [Abstract][Full Text] [Related]
17. Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats.
Rockich K; Blouin R
Drug Metab Dispos; 1999 Sep; 27(9):1074-7. PubMed ID: 10460809
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
[TBL] [Abstract][Full Text] [Related]
19. Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity.
Leclercq I; Horsmans Y; Desager JP; Pauwels S; Geubel AP
Br J Nutr; 1999 Oct; 82(4):257-62. PubMed ID: 10655974
[TBL] [Abstract][Full Text] [Related]
20. The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans.
Poloyac SM; Tosheva RT; Gardner BM; Shedlofsky SI; Blouin RA
Clin Pharmacol Ther; 1999 Dec; 66(6):554-62. PubMed ID: 10613610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
